New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

Eohilia (budesonide) Oral Suspension

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email query@southdelhipharma.com to discuss.

EOHILIA is designed to help reduce the number of eosinophils and other cells that contribute to EoE inflammation. Relief is defined as a decrease in eosinophils (a type of white blood cell) in the esophagus and improvement in dysphagia (difficulty swallowing), as demonstrated by EOHILIA in two 12-week clinical trials.

Brand Name: EOHILIA
Active Ingredient: BUDESONIDE
Dosage Forms And Strengths: • Oral suspension: 2 mg/10 mL single-dose stick packs.
Manufacturer: TAKEDA PHARMACEUTICALS USA INC
FDA-approved use on approval date: For 12 weeks of treatment in adult and pediatric patients 11 years of age and older with eosinophilic esophagitis
Price: On Request

Do you need this medicine in India?

To help you get this medicine – Eohilia (budesonide), a prescription from the Registered Medical Practitioner (RMP) is required. Contact Mr. Tarun at 9891296838 via Call or WhatsApp for availability in India.

Category
Category

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Query Form

Description

Budesonide is given by metered-dose inhaler or nebulizer for maintenance and prophylactic treatment of asthma, including patients who require oral corticosteroids and those who may benefit from a systemic dose reduction.

Inflammatory bowel disease
Formulations of delayed-release budesonide areAsthma an effective treatment for mild-to-moderately active Crohn’s disease involving the ileum and/or ascending colon.

Allergic rhinitis
Budesonide in the form of nasal sprays is a treatment for allergic rhinitis.

Eosinophilic esophagitis
Topical budesonide has considerable effects in eosinophilic esophagitis. For this use, it is formulated as a tablet that disperses in the mouth, and sold under the brand name Jorveza.

Berger’s disease
Budesonide (Tarpeyo (US); Kinpeygo (EU, UK)) is indicated to reduce proteinuria (increased protein levels in the urine) in adults with primary immunoglobulin A (IgA) nephropathy (Berger’s disease) at risk of rapid disease progression.

Nasal budesonide inhalers have been associated with a number of side effects. These include nose irritation or burning, bleeding or sores in the nose, lightheadedness, upset stomach, cough, hoarseness, dry mouth, rash, sore throat, bad taste in mouth, change in mucus, and blurred vision.

EOHILIA (budesonide oral suspension) Initial U.S. Approval: 1997

See full prescribing information : Click Here

Get Access To Eohilia (budesonide) Oral Suspension In India On Request

Brand Name “Eohilia” or Generic Name “budesonide” can be imported for personal use under “Named Patient Program” treatment in Delhi, Kolkata, Surat, Jaipur, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla, Ahmedabad, Jodhpur, Mumbai, Jaipur, Aurangabad, Pune, Bangalore, Hyderabad, Chennai, Visakhapatnam, Coimbatore, Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu, Telangana, India. Contact us at support@southdelhipharma.netsouthdelhipharma@gmail.com or  you can call at 9891296838 or WhatsApp at 9891296838

Related Products